Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The objective of the trial is to demonstrate a statistically significant and clinically relevant disease free survival benefit in stage II and III PIK3CA mutated colon cancer patients taking daily adjuvant aspirin for 3 years.
Inclusion criteria
- PIK3CA mutated colon cancer